CT
CytomX Therapeutics Inc
🇩🇪XFRA.6C1GermanyHealthcare
€2.29EURdown -0.43 (-15.81%)OpenEnd of day12:48 PM
Price€2.29-0.43 (-15.81%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US23284F1057
- CUSIP
- Not reported
Company
- Employees
- 69
- Headquarters
- South San Francisco, United States
- Website
- https://www.cytomx.com
- CEO
- Dr. Sean A. McCarthy DPHIL
Market
- Shares outstanding
- 169.4M
- Market cap
- €388.01M
Highlights
No high and low reported for today's session.
- Market cap
- €388.01M
- EPS LTM
- -$0.47calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- 0.36%
Fundamentals (LTM)
- Revenue
- $18.3M-87.03%down year on year
- Net income
- -$79.65M-266%down year on year
- Gross margin
- 95.84%-3.64%down year on year
- Free cash flow
- -$82.48M-6.18%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.